|
SACM1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77500014686416E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.77129977352308E-10 |
| Normal-vs-Stage2 |
1.82059999997985E-06 |
| Normal-vs-Stage3 |
2.0567999969856E-08 |
| Normal-vs-Stage4 |
1.81370000129633E-08 |
| Stage1-vs-Stage2 |
9.709800E-01 |
| Stage1-vs-Stage3 |
4.529600E-01 |
| Stage1-vs-Stage4 |
2.836400E-02 |
| Stage2-vs-Stage3 |
5.638400E-01 |
| Stage2-vs-Stage4 |
1.686970E-01 |
| Stage3-vs-Stage4 |
3.613800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.58280105372933E-11 |
| Normal-vs-AfricanAmerican |
3.02240000027432E-07 |
| Normal-vs-Asian |
2.522000E-01 |
| Caucasian-vs-AfricanAmerican |
4.471600E-01 |
| Caucasian-vs-Asian |
4.265400E-01 |
| AfricanAmerican-vs-Asian |
6.061200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.97839522542154E-11 |
| Normal-vs-Female |
1.79242999999163E-05 |
| Male-vs-Female |
1.339760E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.06190000004336E-06 |
| Normal-vs-Extreme_Weight |
1.91699989215977E-10 |
| Normal-vs-Obese |
1.00459999985425E-07 |
| Normal-vs-Extreme_Obese |
4.628200E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.681400E-01 |
| Normal_Weight-vs-Obese |
7.977000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.485000E-01 |
| Extreme_Weight-vs-Obese |
2.264600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.104400E-01 |
| Obese-vs-Extreme_Obese |
5.493600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.430200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.56470003620512E-09 |
| Normal-vs-Age(61-80Yrs) |
2.0718005089293E-10 |
| Normal-vs-Age(81-100Yrs) |
2.60060000001339E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.696000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.852600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.571800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.848800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.433000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.925600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.76810052446797E-10 |
| Normal-VS-Type2 PRCC |
4.92859975054216E-10 |
| Normal-VS-KIRP CIMP |
7.7651999996764E-07 |
| Normal-VS-Unclassified PRCC |
3.28039999997198E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.039200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.473200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.183800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.440400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.436000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.043200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.81069945096135E-10 |
| Normal-vs-N1 |
9.58455537158898E-13 |
| Normal-vs-N2 |
5.50059999999686E-05 |
| N0-vs-N1 |
2.699200E-01 |
| N0-vs-N2 |
2.547200E-01 |
| N1-vs-N2 |
1.731840E-01 |
|
|
